| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235929 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 8 Pages |
Abstract
The results of our study have shown that high-frequency SNHL is significantly related to the mean cochlea dose and the concurrent cisplatin dose. A mean dose constraint of 47 Gy to the cochlea is recommended to minimize SNHL after chemoradiotherapy.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
S.H. F.R.C.R., W.T. F.R.C.R., K.L. F.R.C.S., Michael C.H. Ph.D., C.W. M.Sc., T.K. F.R.C.R., Anne W.M. F.R.C.R., S.K. F.R.C.S.,